2GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
3Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
4Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.
6Zhang JP,Kang J,et al. Effect of carbocysteine On acute exacerbation of Chronic obstructive Pulmonary disease (PEACE Study)..a randomized Placebo-controlled study [J]. Lancet, 2008,371(9629) : 2013-2018.
7Lipworth BJ.Phosphodiesterase-4 inhibitors for &sthm& and chronic obstructive pulmon&ry dise&se[J]. L&ncet, 2005,565:167-175.
8Tashkin DP,Oelli B,Senn S,et aI.A 4-year trial of tiotrop'ium in chronic obstructive pulmonary disease[J].N Engl J Med,2008,359:1543- 1554.
9CosioBG,LglesiasA,l oisA,et aI.Low-dose theophylline enh&nces the &nti-infiam-m&tory effeets of steroids during exacerbation of COPD[J]. Thorax, 2009,64. 424-429.
10Cola C,Almeida M,Li D,et aI.FLegulatory role of endothelium in the expression of genes ffectJng arteria calcification[J].BJochem Biophys P es Commun, 2004,320(2) : 424-427.
